Cardiovascular(心血管)

Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
Products for Cardiovascular
- Acute Phase Reactants(16)
- Angina(14)
- Arrhythmia(82)
- Atherosclerosis(86)
- Cardiomyopathy(5)
- Cholesterol Metabolism(43)
- Chronic Kidney Disease(17)
- Coagulation & Hemostasis(123)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(8)
- Endothelium(32)
- Erythrocytes & Hemoglobin(51)
- Heart Failure(31)
- Hypertension(162)
- Hypotension(23)
- Lipoproteins(60)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(60)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(36)
- Storage & Transport(6)
- Stroke(49)
- Vasoconstriction(59)
- Thrombosis(53)
- Vasodilation(138)
- Cat.No. 产品名称 Information
-
GC47021
Caloxin 2A1 (trifluoroacetate salt)
VSNSNWPSFPSSGGG-NH2
A neuropeptide with diverse biological activities -
GC43136
Campestanol
油菜甾醇
A phytosterol
-
GC63573
Cannabigerol monomethyl ether
O-methyl Cannabigerol, Cannabigerol monomethyl ether
An Analytical Reference Standard -
GC49433
Capsiate
辣椒素酯
A capsaicin analog with diverse biological activities -
GC43140
Captopril Disulfide
卡托普利二硫化物,SQ 14551
A metabolite and degradation product of captopril -
GC45398
Captopril-d3
卡托普利-D3,SQ 14225-d3
An internal standard for the quantification of captopril -
GC49564
Carazolol-d7
咔唑-D7,(±)-Carazolol-d7; DL-Carazolol-d7; Suacron-d7
An internal standard for the quantification of carazolol -
GC41449
Carbazeran
卡巴折伦
An inhibitor of PDE2 and PDE3 -
GC49197
Carbinoxamine-d6 (maleate)
An internal standard for the quantification of carbinoxamine
-
GC18837
Carbocyclic Thromboxane A2
Carbocyclic TXA2, CTA2
A TXA2 analog with vasoconstrictor and anti-platelet aggregation activity
-
GC47045
Carvedilol-d5
卡维地洛-D5,BM 14190-d5
An internal standard for the quantification of carvedilol -
GC43146
Caspase-9 Inhibitor III (trifluoroacetate salt)
Ac-LEHD-CMK
A caspase-9 inhibitor -
GC52389
Caveolin-1 (82-101) amide (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)
Cav-1, Caveolin-1 Scaffolding Domain Peptide, CSD, CSP, DGIWKASFTTFTVTKYWFYR-NH2
A synthetic peptide fragment of caveolin-1 -
GC43160
CAY10485
3,4dihydroxy Hydrocinnamic acid (LAspartic acid dibenzyl ester) amide
An ACAT-1 and -2 inhibitor with antioxidant activity -
GC40869
CAY10486
4Hydroxycinnamic acid (Lphenylalanine methyl ester) amide
An inhibitor of ACAT -
GC41636
CAY10487
3,4Dihydrocinnamic Acid (Lalanine methyl ester) amide
An antioxidant with anti-atherogenic activity -
GC43166
CAY10535
A TPβ selective antagonist
-
GC41381
CAY10562
4phenyl1,3,2Oxathiazolylium5olate
A pH-controlled nitric oxide donor -
GC43180
CAY10592
A selective partial PPARδ agonist
-
GC18879
CAY10662
A urea derivative of 17(18)-EpETE
-
GC18698
CAY10665
A stable bioisostere of the antiarrhythmic 17,18-EET
-
GC47053
CAY10746
A ROCK1 and ROCK2 inhibitor
-
GC52006
CB-096
An inhibitor of RAN translation
-
GC49706
Cerberin
海果苷
A cardiac glycoside with cytotoxic and cardiac modulatory activities -
GC43233
CG 4305
A stable PGI2 analog with antithrombotic properties
-
GC52438
CGRP (8-37) (mouse, rat) (trifluoroacetate salt)
Calcitonin Gene-Related Peptide (8-37), CGRP8-37, VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2
A CGRP receptor antagonist -
GC43242
Chloramphenicol Succinate
琥珀酸氯霉素
A prodrug form of chloramphenicol -
GC45885
Chloroquine-d5 (phosphate)
磷酸氯喹 d5 (二磷酸盐)
An internal standard for the quantification of chloroquine -
GC43247
Chlorthalidone Impurity G
氯噻酮杂质G
A potential impurity in commercial chlorthalidone preparations -
GC40203
Cholesterol-d6
胆固醇-26,26,26,27,27,27-D6
An internal standard for the quantification of cholesterol -
GC47085
Cholesterol-d7
胆固醇 d7
An internal standard for the quantification of cholesterol -
GC19433
Cholesteryl Heptadecanoate
胆固醇七癸酸盐
An internal standard for quantification of cholesterol esters -
GC43260
Cholesteryl Linoleate Hydroperoxides
Contains a mixture of racemic 9- and 13-HpODE cholesteryl esters
-
GC43263
Cholesteryl Stearate
胆甾醇硬脂酸酯
A cholesterol ester -
GC47088
Cilostazol-d4
西洛他唑-D4,OPC-13013-d4
An internal standard for the quantification of cilostazol -
GC43270
Ciprostene (calcium salt)
Ciprostene calcium, U61431F
A stable analog of PGI2 -
GC52327
Ciraparantag (trifluoroacetate salt)
PER977
An anticoagulant reversal agent -
GC63629
cis-2-Butene-1,4-diol
顺式-1,2-二羟甲基乙烯
cis-2-Butene-1,4-diol 是一种用于合成抗病毒药物 oxetanocin A 的化合物。cis-2-Butene-1,4-diol 是研究异构化与氢化和氢解反应的探针。 -
GC47096
Citrinin-13C13
(-)-Citrinin-13C13, CTN-13C13
A neuropeptide with diverse biological activities -
GC52351
Citrullinated α-Enolase (R8 + R14) (1-19)-biotin Peptide
Citrullinated Enolase-1-biotin, α-Enolase Peptide (Citrulline Residues 8 + 14)
A biotinylated and citrullinated α-enolase peptide -
GC90750
cKK-E15
一种可离子化的阳离子脂质
-
GC49556
Cl-Necrostatin-1
7-Cl-Nec-1, 7-Cl-Necrostatin-1, Nec-1f
A RIPK1 inhibitor -
GC90993
CL4F8-6
一种可离子化的阳离子脂质
-
GC62690
CL4H6
CL4H6 是一种 pH 敏感的阳离子脂质。
-
GC47100
Clevidipine-d7
氯维地平 d7
A neuropeptide with diverse biological activities -
GC47103
Clonidine-d4 (hydrochloride)
可乐定 d4 (盐酸盐)
An internal standard for the quantification of clonidine -
GC43281
Clopidogrel Carboxylic Acid (hydrochloride)
(S)-(O-氯苯基)-6,7-二羟噻吩[3,2-C]吡啶-5(4H)-醋酸盐酸盐
A major inactive metabolite of clopidogrel -
GC40632
CMS121
CMS121是一种口服有效的乙酰辅酶A羧化酶1(ACC1)抑制剂。
-
GP10134
coagulation factor II (thrombin) B chain fragment [Homo sapiens]
H2N-Lys-Pro-Val-Ala-Phe-Ser-Asp-Tyr-Ile-His-Pro-Val-Cys-Leu-Pro-Asp-Arg-OH
Trypsin-like serine protease
-
GC49096
Cobaltic Protoporphyrin IX (chloride)
原卟啉氯化钴
Cobaltic Protoporphyrin IX (chloride)是一种高价钴配位卟啉化合物。Cobaltic Protoporphyrin IX (chloride)通过上调HO-1的抗氧化、抗炎和细胞保护功能,有助于减轻免疫相关的肾脏损伤。